Nanocarriers for brain specific delivery of anti-retro viral drugs: challenges and achievements |
| |
Authors: | Nila Mary Varghese Shailendra K. Saxena |
| |
Affiliation: | 1. Department of Pharmaceutics, JSS College of Pharmacy, Ootacamund, Jagadguru Sri Shivarathreeswara University, Mysuru, India;2. Centre for Advance Research (CFAR), King George’s Medical University (KGMU), Lucknow, India |
| |
Abstract: | HIV/AIDS is a global pandemic and the deleterious effects of human immunodeficiency virus in the brain cannot be overlooked. Though the current anti-retro viral therapy is able to reduce the virus load in the peripheral tissues of the body, the inability of the anti-retro viral drugs to cross the blood brain barrier, as such, limits its therapeutic effect in the brain. The development of newer, successful nanoparticulate drug delivery systems to enhance the feasibility of the anti-retro viral drugs to the brain, offers a novel strategy to treat the AIDS-related neuronal degradation. This review summarised the neuropathogenesis of neuroAIDS, the challenges and achievements made in the delivery of therapeutics across the BBB and the use of nanocarriers as a safe and effective way for delivering anti-retro viral drugs to the brain. |
| |
Keywords: | HIV blood brain barrier transport systems nanocarriers brain targeted drug delivery systems |
|
|